These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 20107770

  • 1. Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats.
    Weiss CS, Hagenmüller M, Pichler M, Münz S, Ochs M, Buss SJ, Bekeredjian R, Katus HA, Hardt SE.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):285-95. PubMed ID: 20107770
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats.
    Shinzato T, Ohya Y, Nakamoto M, Ishida A, Takishita S.
    Hypertens Res; 2007 Sep; 30(9):863-73. PubMed ID: 18037780
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
    Asakawa M, Takano H, Nagai T, Uozumi H, Hasegawa H, Kubota N, Saito T, Masuda Y, Kadowaki T, Komuro I.
    Circulation; 2002 Mar 12; 105(10):1240-6. PubMed ID: 11889020
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
    Kato MF, Shibata R, Obata K, Miyachi M, Yazawa H, Tsuboi K, Yamada T, Nishizawa T, Noda A, Cheng XW, Murate T, Koike Y, Murohara T, Yokota M, Nagata K.
    J Hypertens; 2008 Aug 12; 26(8):1669-76. PubMed ID: 18622247
    [Abstract] [Full Text] [Related]

  • 5. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding.
    Feldman AM, Weinberg EO, Ray PE, Lorell BH.
    Circ Res; 1993 Jul 12; 73(1):184-92. PubMed ID: 8508529
    [Abstract] [Full Text] [Related]

  • 6. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M, Balakumar P, Singh M.
    Pharmacology; 2007 Jul 12; 80(2-3):177-84. PubMed ID: 17570955
    [Abstract] [Full Text] [Related]

  • 7. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P, Yang W, Wu SM, Sheng L.
    Methods Find Exp Clin Pharmacol; 2006 Dec 12; 28(10):691-6. PubMed ID: 17235413
    [Abstract] [Full Text] [Related]

  • 8. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
    Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA.
    Diabetes; 2008 Sep 12; 57(9):2470-9. PubMed ID: 18511847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
    Engle SK, Solter PF, Credille KM, Bull CM, Adams S, Berna MJ, Schultze AE, Rothstein EC, Cockman MD, Pritt ML, Liu H, Lu Y, Chiang AY, Watson DE.
    Toxicol Sci; 2010 Apr 12; 114(2):183-92. PubMed ID: 20044590
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH.
    Circulation; 1994 Sep 12; 90(3):1410-22. PubMed ID: 8087951
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pressure-volume analysis reveals characteristic sex-related differences in cardiac function in a rat model of aortic banding-induced myocardial hypertrophy.
    Ruppert M, Korkmaz-Icöz S, Loganathan S, Jiang W, Lehmann L, Oláh A, Sayour AA, Barta BA, Merkely B, Karck M, Radovits T, Szabó G.
    Am J Physiol Heart Circ Physiol; 2018 Sep 01; 315(3):H502-H511. PubMed ID: 29799277
    [Abstract] [Full Text] [Related]

  • 14. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.
    Pharmacology; 2007 Sep 01; 79(3):184-92. PubMed ID: 17356310
    [Abstract] [Full Text] [Related]

  • 15. Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension.
    Nakamoto M, Ohya Y, Shinzato T, Mano R, Yamazato M, Sakima A, Takishita S.
    Hypertens Res; 2008 Feb 01; 31(2):353-61. PubMed ID: 18360056
    [Abstract] [Full Text] [Related]

  • 16. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A, Trappiel M, Berghausen EM, Ten Freyhaus H, Wellnhofer E, Odenthal M, Blaschke F, Er F, Gassanov N, Rosenkranz S, Baldus S, Kappert K, Caglayan E.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 01; 389(4):369-79. PubMed ID: 26742933
    [Abstract] [Full Text] [Related]

  • 17. [Pioglitazone protects against elastocalcinosis and improves aortic wall elasticity].
    Lartaud I, Gaillard V, Dauca M, Atkinson J.
    Ann Pharm Fr; 2007 May 01; 65(3):189-94. PubMed ID: 17489075
    [Abstract] [Full Text] [Related]

  • 18. Regression of pressure overload-induced left ventricular hypertrophy in mice.
    Gao XM, Kiriazis H, Moore XL, Feng XH, Sheppard K, Dart A, Du XJ.
    Am J Physiol Heart Circ Physiol; 2005 Jun 01; 288(6):H2702-7. PubMed ID: 15665058
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S, Long CL, Wang RH, Wang H.
    Cardiovasc Res; 2009 Aug 01; 83(3):444-56. PubMed ID: 19304734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.